Generium is a Russian innovative biotechnology company, combining a world-class research institute, a center for managing preclinical and clinical studies and high-tech production.

The company operates its own R&D park, capable of developing any drug, from molecule creation to industrial-scale production, including chemical synthesis, gene therapy and cell products.